Previous studies [34, 35] involving leukemia and breast cancer models have revealed that CDK1 relies more on CDK7-mediated activation activity and stability, while other CDK-activating kinases can also regulate CDK2, in addition to CDK7. This evidence concerns the gene CDK7 and leukemia.